Boston, MA · Founded 2018 · Privately Held (backing)
Developer of targeted RNA-modulating therapeutics designed for the treatment of genetically defined diseases. Atalanta Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $45 million in Jun 2018. It has raised $227 million.
Last reported valuation
$45.0M
Oct 2026
Priced at
—
Total raised
$227.0M
Last round
—
Team — not yet on record
No current team members for Atalanta Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Atalanta Therapeutics with a free account
·The complete investor list: 11 names
·Watch Atalanta Therapeutics: the Monday email on marks, rounds and moves
